These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19716852)

  • 1. Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing.
    Koh CG; Zhang X; Liu S; Golan S; Yu B; Yang X; Guan J; Jin Y; Talmon Y; Muthusamy N; Chan KK; Byrd JC; Lee RJ; Marcucci G; Lee LJ
    J Control Release; 2010 Jan; 141(1):62-9. PubMed ID: 19716852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.
    Yang X; Koh CG; Liu S; Pan X; Santhanam R; Yu B; Peng Y; Pang J; Golan S; Talmon Y; Jin Y; Muthusamy N; Byrd JC; Chan KK; Lee LJ; Marcucci G; Lee RJ
    Mol Pharm; 2009; 6(1):221-30. PubMed ID: 19183107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes.
    Chiu SJ; Liu S; Perrotti D; Marcucci G; Lee RJ
    J Control Release; 2006 May; 112(2):199-207. PubMed ID: 16564596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.
    Zhang X; Koh CG; Yu B; Liu S; Piao L; Marcucci G; Lee RJ; Lee LJ
    Pharm Res; 2009 Jun; 26(6):1516-24. PubMed ID: 19291371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.
    Jin Y; Liu S; Yu B; Golan S; Koh CG; Yang J; Huynh L; Yang X; Pang J; Muthusamy N; Chan KK; Byrd JC; Talmon Y; Lee LJ; Lee RJ; Marcucci G
    Mol Pharm; 2010 Feb; 7(1):196-206. PubMed ID: 19852511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139.
    Weecharangsan W; Yu B; Liu S; Pang JX; Lee LJ; Marcucci G; Lee RJ
    Anticancer Res; 2010 Jan; 30(1):31-7. PubMed ID: 20150614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coaxial electrohydrodynamic spraying: a novel one-step technique to prepare oligodeoxynucleotide encapsulated lipoplex nanoparticles.
    Wu Y; Yu B; Jackson A; Zha W; Lee LJ; Wyslouzil BE
    Mol Pharm; 2009; 6(5):1371-9. PubMed ID: 19499922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of plasmid DNA and antisense oligodeoxyribonucleotide into human carcinoma cells by cationic liposomes.
    Weecharangsan W; Opanasopit P; Yingyongnarongkul BE; Kewsuwan P; Lee RJ
    Curr Pharm Biotechnol; 2014; 15(9):790-9. PubMed ID: 25307014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.
    Cheng X; Liu Q; Li H; Kang C; Liu Y; Guo T; Shang K; Yan C; Cheng G; Lee RJ
    Pharm Res; 2017 Feb; 34(2):310-320. PubMed ID: 27896589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition and chemosensitization of human carcinoma cells by human serum albumin-coated liposomal antisense oligodeoxyribonucleotide against bcl-2.
    Weecharangsan W; Lee RJ
    Drug Deliv; 2012 Aug; 19(6):292-7. PubMed ID: 22931245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient delivery of antisense oligodeoxyribonucleotide g3139 by human serum albumin-coated liposomes.
    Weecharangsan W; Yu B; Zheng Y; Liu S; Pang JX; Lee LJ; Marcucci G; Lee RJ
    Mol Pharm; 2009; 6(6):1848-55. PubMed ID: 19725564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic assembly of lipid nanoparticles for delivery of antisense oligonucleotides.
    Zhou Y; Meng Z; Guo T; Fu Y; Lee RJ; Xie J
    Curr Pharm Biotechnol; 2014; 15(9):823-8. PubMed ID: 25335534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
    J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic generation of chitosan/CpG oligodeoxynucleotide nanoparticles with enhanced cellular uptake and immunostimulatory properties.
    Chen S; Zhang H; Shi X; Wu H; Hanagata N
    Lab Chip; 2014 Jun; 14(11):1842-9. PubMed ID: 24733088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-step microfluidic synthesis of transferrin-conjugated lipid nanoparticles for siRNA delivery.
    Li Y; Lee RJ; Huang X; Li Y; Lv B; Wang T; Qi Y; Hao F; Lu J; Meng Q; Teng L; Zhou Y; Xie J; Teng L
    Nanomedicine; 2017 Feb; 13(2):371-381. PubMed ID: 27720989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
    Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
    Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid of niosomes and bio-synthesized selenium nanoparticles as a novel approach in drug delivery for cancer treatment.
    Gharbavi M; Johari B; Mousazadeh N; Rahimi B; Leilan MP; Eslami SS; Sharafi A
    Mol Biol Rep; 2020 Sep; 47(9):6517-6529. PubMed ID: 32767222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects.
    Hu Q; Shew CR; Bally MB; Madden TD
    Biochim Biophys Acta; 2001 Sep; 1514(1):1-13. PubMed ID: 11513800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.